top of page




Guzman et al. 2018

doi: 10.1161/STROKEAHA.117.018288.

Ti-com was registered in 2018 to commercialize the scientific discoveries of its founders, who are accomplished researchers with more than ten years of experience in leading academic institutions around the World. They spearheaded multi-million projects in Poland and abroad, related to precision medicine with particular emphasis on biomaterial science, imaging and regenerative medicine.

Meet Some of Our Partners
  • Miguel Oliveira, University of Minho, Portugal

  • Novamatrix, Norway

  • Johannes Boltze, University of Warwick, Great Britain

  • Jesus Ruiz-Cabello, CIC biomaGUNE, Spain

  • Shen Li, Dalian Municipal Hospital, China

  • Xunming Ji, Xuanwu Hospital, China

  • Hoshi University School of Pharmacyand Pharmaceutical Sciences, Japan

  • Kannie Chan, The City University of Hong Kong

  • Jan Gettemans, University of Ghent, Belgium

  • Pavla Jendelova, Univeristy of Prague, Czech Republic

  • Raphael Guzman, University of Basel, Switzerland

  • Tim Magnus, University of Hamburg, Germany

  • Ulf Kahlert, Heinrich Heine University Düsseldorf, Germany

  • Donata Maciaczyk, University of Otago, Dunedin, New Zealand 

  • Syed Shadab Raza, Era University, India

  • Ralph Santos-Oliveira, Brazilian Association of Radiopharmacy, Brazil

bottom of page